Background: The findings of currently available studies are not consistent with regard to the association between the risk of cancer and ginseng consumption. Therefore, we aimed to evaluate this association by conducting a meta-analysis of different studies. Methods: To systematically evaluate the effect of ginseng consumption on cancer incidence, six databases were searched, including PubMed, Ovid Technologies, Embase, The Cochrane Library, China National Knowledge Infrastructure, and Chinese VIP Information, from 1990 to 2014. Statistical analyses based on the protocol employed for a systematic review were conducted to calculate the summary relative risks (RRs) and 95% confidence intervals (CIs). Results: We identified nine studies, including five cohort studies, three case-control studies, and one randomized controlled trial, evaluating the association between ginseng consumption and cancer risk; these studies involved 7,436 cases and 334,544 participants. The data from the meta-analysis indicated a significant 16% lower risk of developing cancer in patients who consumed ginseng (RR ¼ 0.84, 95% CI ¼ 0.76e0.92), with evidence of heterogeneity (p ¼ 0.0007, I
Introduction
Cancer imposes a global threat to public health. According to the Global Cancer Statistics estimates, there were about 14.1 million new cancer cases and 8.2 million cancer deaths in 2012 [1] . Importantly, these numbers have rapidly increased with increased population growth and environmental pollution. Malignancy results from complex interactions among multiple genes, the intracellular environment, and neighboring tissues [2] . The basic theory of tumorigenesis suggests that the process starts with a normal cell that is transformed through the activation of proto-oncogenes and the suppression of tumor suppressor genes. After the transformation, the cell does not behave like a normal cell, but instead begins to exhibit the properties of a cancer cell. These transformed cells acquire the capability to proliferate uncontrollably through self-sufficiency in growth signals and are insensitive to antigrowth signals. In addition, they are able to evade apoptosis, eventually resulting in tumor growth. As the tumor continues to develop, its growth is aided by the development of new blood vessels that provide it with nutrients, thereby allowing it to sustain itself and even invade other tissues, resulting in metastasis that is ultimately lethal [2e5] .
Chemoprevention is defined as the use of natural, synthetic, or biological agents to prevent, suppress, and reverse the carcinogenic progression. It is ideally effective in prevention of the disease and should be nontoxic. Chemoprevention is characterized by the disruption of, or at least the delay of, multiple pathways and processes in the three stages of carcinogenesis, namely, initiation, promotion, and progression [6, 7] . Chemicals or biomolecules that inhibit the initiation stage are necessary for the preservation of DNA [8, 9] . In contrast to compounds that preserve DNA, compounds that affect the later stages of carcinogenesis (promotion and progression) are known for their ability to decrease the proliferative capacity of initiated cells. They interfere with cancer cell proliferation by downregulating the expression of the molecules involved in signal-transduction pathways, such as nuclear factor kappa-light-chain enhancer of activated B cells (NF-kB), mammalian target of rapamycin, and signal transducer and activator of transcription 3, and by inhibiting cytochrome P 450 enzymes that modulate signal transduction to hormone-responsive elements [10] . In addition, suppressing agents are likely to reduce or delay the ability of cancer cells to acquire metastatic properties by promoting pathways leading to apoptosis [11] and inhibiting pathways leading to angiogenesis, epithelial mesenchymal transition, invasion, and dissemination [12] .
Traditional herbal medicine used for thousands of years is advantageous in maintaining a balanced health status and help prevent further diseases in a safe and effective manner. Ginseng (Panax ginseng Meyer) is widely used and has been included in pharmacopoeias in China, Japan, Germany, France, Austria, and the United Kingdom. It is widely available as an over-the-counter drug and also commonly used as an adjuvant to increase human immunity [13, 14] . Furthermore, the protective effect of ginseng in cancer chemoprevention has been shown by extensive laboratory and preclinical studies [15] . Ginseng is chemoprophylactic and often acts on its cellular and molecular targets through various signaling pathways, thereby inhibiting the tumor by regulation of the cell cycle, induction of apoptosis, and inhibition of angiogenesis and invasion [16, 17] . The anticancer effects of ginseng involve modulation of diverse signaling pathways, including regulation of cell proliferation mediators (cyclin-dependent kinases and cyclins), growth factors (c-myc, epidermal growth factor receptor, and vascular endothelial growth factor), tumor suppressors (p53 and p21), oncogenes (MDM2), cell death mediators [B-cell lymphoma 2 (Bcl-2), B-cell lymphoma-extra large (Bcl-xL), X-linked inhibitor of apoptosis protein (XIAP), caspases, and death receptors], inflammatory response molecules (NF-kB and cyclooxygenase-2), and protein kinases (c-Jun N-terminal protein kinase, Akt, and adenosine monophosphate-activated protein kinase) [18] . During the past decade, although a series of epidemiologic studies had indicated that ginseng consumption affects cancer incidence, the results of the studies are inconsistent. Therefore, a quantitative analysis of the associations between ginseng consumption and risk of cancer was necessary to expound the existing inconsistency in the literature. Thus, a meta-analysis aimed at reviewing and summarizing the relationship between ginseng consumption and risk of cancer was performed, and different relative risk (RR) ratios of cancer were determined by performing subgroup analyses.
Materials and methods

Search strategy
We conducted a literature search for relevant articles in PubMed, Ovid Technologies, Embase, Cochrane Library, China National Knowledge Infrastructure, and Chinese VIP Information for published papers from 1990 to July 2014 using the following search terms without language restrictions: "ginseng," "fresh ginseng," "white ginseng," "red ginseng," "ginseng supplement," "ginseng or fresh ginseng or white ginseng or red ginseng or ginseng supplement," "Neoplasms" (Mesh), "randomized controlled trial," "cohort," "case control," "randomized controlled trial or cohort or case control," "ginseng or fresh ginseng or white ginseng or red ginseng or ginseng supplement and neoplasms (Mesh) and randomized controlled trial or cohort or case control."
In addition, the reference lists of the selected articles were also reviewed to identify other relevant articles. The research was conducting by two authors on their own account.
Study selection
The following criteria were chosen to identify the studies for this meta-analysis: studies comprising a randomized controlled trial or observation study with the exposure factor being ginseng intake, studies with risk of cancer being the end point of interest, and studies in which risk estimates were reported. If data were included more than once, the latest and complete research was chosen.
Data extraction and quality assessment
The data were charted as follows: first author, publication year, study design, region, study period, case and control, ginseng type and consumption, RR, and confounding factors of interest. The included studies were independently evaluated by two authors using the methodological quality assessment system in RevMan 5.3. Discrepancies in evaluation were resolved by a third author, and potential publication bias was examined using Begg's test. A linear regression approach was used to measure the funnel plot asymmetry on the natural logarithm scale of the RR ratios [19] .
Statistical analysis
The main analyses were focused on the associations between consumption of ginseng and cancer incidence. In addition, the RR of lung cancer, colorectal cancer (cancer of the colon and rectum), gastric cancer (cancer of the stomach), and liver cancer was determined in relation to ginseng consumptions in a subgroup analysis.
All analyses were performed using Review Manager version 5.3 (Cochrane Collaboration software) and GRADE profiler version 3.6.
All p values are two-sided and p < 0.1 was considered significant. Furthermore, the I 2 index, a quantitative measure of inconsistency, across studies was calculated [20] .
Results
Literature search
A flowchart showing the study selection process is presented in Fig. 1 . In brief, a total of 4,619 publications and 18 studies that are currently underway were identified. A total of 1,205 duplicates were then removed. After screening the abstracts, we excluded the duplicates, studies involving animal experiments and in vitro analyses, ingredient experimental studies, and reviews, etc. for not meeting the inclusion criteria. After evaluating the full manuscripts of the 46 potentially relevant articles, 37 potentially relevant studies were excluded further because they were not related to the to the risk ratio of cancer in humans and nonginseng use in experimental group. Finally, nine studies were selected for analysis [21e29].
Study characteristics
The included studies were identified with regard to ginseng consumption, and risk of cancer in this meta-analysis is presented in [21, 28, 29] , and one study each assessed prostate cancer [24] , hematologic malignancies [25] , and breast cancer [27] .
Quality assessment of the included studies
The Cochrane risk of bias tool was used to assess risk bias (Figs. 2  and 3 ). Because eight of the studies were observation studies, the random sequence generation, allocation concealment, and blinding of participants and personnel all showed high risk. Most of the studies involved questionnaire analysis, and the participants were in different hospitals by randomized doctors. Therefore, blinding of outcome assessment showed low risk. In addition, outcome data loss was less than 20%, and therefore, incomplete outcome data presented a low risk. Because the protocols of all the trials were not accessible, selective reporting was generally unclear. Therefore, the grading of recommendations assessment results is shown with a low quality of evidence (Table 2) .
Main analysis
A total of nine studies were included in this meta-analysis to evaluate the association between ginseng intake and the risk of cancer. There was a significant 16% lower cancer risk associated with ginseng consumption in comparison with the risk associated with no ginseng consumption for all studies combined [RR ¼ 0.84, 95% confidence interval (CI) ¼ 0.76e0.92], with evidence of heterogeneity (p ¼ 0.0007, I
2 ¼ 70%) in Fig. 4 .
Publication bias
There was no significant combined publication bias in all studies assessing the relationship between ginseng intake and cancer incidence, as suggested by Begg's rank correlation test in Fig. 5 (p for Begg's test was 0.596). However, the study by Kamangar et al [22] may have had a high bias. When this study was excluded from this meta-analysis, we observed a significant 19% lower risk of developing cancer after ginseng consumption in comparison with the risk without ginseng consumption (RR ¼ 0.81, 95% CI ¼ 0.76e0.85), with low heterogeneity (p ¼ 0.20, I 2 ¼ 28%).
Subgroup and sensitivity analyses
The subgroup analyses according to the type of cancer are presented in Table 3 . When the analyses were stratified by cancer site, the summary RRs for ginseng intake versus no ginseng consumption were 0.77 for lung cancer, 0.83 for gastric cancer, 0.81 for liver cancer, and 0.77 for colorectal cancer. Evidence of heterogeneity was observed only in the gastric cancer subgroup (Fig. 6) . In addition, sensitivity analysis indicated that the summary estimates (RR ¼ 0.81, 95% CI ¼ 0.76e0.85) showed low heterogeneity (p ¼ 0.20, I
2 ¼ 28%) when the study by Kamangar et al [22] was excluded. Meanwhile, in the gastric cancer subgroup, the sensitivity analysis also indicated that when the Kamangar et al [22] study was excluded, the summary estimates changed (RR ¼ 0.70, 95% CI ¼ 0.62e0.79), with no significant heterogeneity (p ¼ 0.59, I 2 ¼ 0%).
Discussion
The present meta-analysis, based on the latest published results, is the first quantitative systematic analysis of the association between ginseng consumption and cancer risk in 7,436 cases and 334,544 participants. The meta-analysis of the studies identified indicated that ginseng consumption may be associated with a reduced risk of cancer. We found substantial heterogeneity in the association between ginseng consumption and cancer risk across studies. This is not surprising given the variation in study designs and characteristics of the study populations. However, the stratified analysis by cancer type showed significant heterogeneity only for gastric cancer. It indicated that gastric cancer may be the major source of heterogeneity. Furthermore, when we separated the population in Shanghai, China [22] from others in Seoul, Korea [21, 28, 29] , the results indicated no significant inverse association between ginseng consumption and gastric cancer risk. Because the Most were observational studies.
2)
Other factor may affect the results.
3)
Some of studies described the dose-response.
CI, confidence interval; RR, relative risk.
chemical components of ginseng differ by region, the inclusion of studies from different regions may have been responsible for the heterogeneity. Moreover, the exposure factor may be greater, because patient information obtained after diagnoses in an observation study could also result in systematic errors. However, the fact that large numbers of cases and controls were involved in this meta-analysis also means that the findings about association between ginseng consumption and the risk of cancer are more reliable. In addition, we found a significant association between ginseng intake and reduction of cancer incidence, which further strengthened our result. The basic mechanism of cancer development is now known to result from an accumulation of genetic and epigenetic alterations in cells [30] . Although diagnosis and treatment are the major strategies for controlling cancer, the importance of cancer chemoprevention has gradually increased because advanced cancer is difficult to cure [31, 32] .
Ginseng, a famous traditional Chinese medicine, has been used for thousands of years [33] . Its usefulness in cancer prevention and therapy has been shown by extensive preclinical and epidemiological studies [34e36] . The main active ingredients of ginseng are often thought to be ginsenosides. The anticancer effects of ginseng involve diverse molecular mechanisms of action, which in turn involve the regulation of most known modulators of carcinogenesis [19] . Because ginsenosides cause tumor cell death through various mechanisms, it may be difficult for cells to develop resistance to ginsenoside-induced death. Furthermore, the ability of ginsenosides to kill tumor cells and relative nontoxicity to normal cells make them attractive candidates for drug development [37] . The diverse properties of ginseng are attributable to the diversity in both chemical structure and biological activity.
The study by Kamangar et al [22] showed opposite effects. The types of ginseng used by the participants in their study were similar to those used in other studies. However, the group and its extension were selected from among patients who were also referred to other studies included in this meta-analysis. Therefore, the sex of the patients included was significantly different from others. The prevalence of sex differences might have led to greater bias in this group than in the general population because of the differences in lifestyle and genetic constitution of female participants. Therefore, further evaluation of the association between ginseng consumption and sex may be needed to clarify ginseng's role in cancer.
Several potential limitations of our meta-analysis should be considered while interpreting the results. First, most of the studies included were observational studies, and the presence of cohort and case-control studies may have introduced confounding factors and biases as a result of the different methods used in the studies. Second, studies included were mainly conducted in Korea, China, and the United States; therefore, the data should be extrapolated to other populations with caution. Third, the apparent protective effect of ginseng against cancer may be also attributable to genetic and other environmental factors. Finally, the articles included in our meta-analysis were published in journals. Unpublished studies and original data were not included. However, our meta-analysis also has several strengths. In particular, it allowed us to directly address the association between ginseng consumption and cancer risk in humans, avoiding the uncertainties derived from the use of animal data and mathematical models, and to assess the public health relevance of such a relation. Previous epidemiological studies have already identified several dietary and nutritional factors associated with the risk of various cancers, particularly those of the digestive tract. This weighs in favor of the capability of epidemiological studies included in this meta-analysis to assess the association of cancer with ginseng consumption.
Conclusion
To the best of our knowledge, this review is the first to systematically perform a quantitative evaluation of the chemopreventive effect of ginseng on the incidence of cancer, addressing the lack of this type of research. In summary, ginseng consumption was associated with a significantly lower risk of developing cancer. However, the findings should be interpreted with caution due to the low quality of the included trials. Rigorous multicenter, largescale clinical trials should be carried out to reveal the exact effectiveness in the future.
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